Fingerprint
Dive into the research topics where Hafsah Nabi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
Safety outcomes in 2132 Danish patients with inflammatory arthritis treated with biosimilar infliximab (GP1111) in routine care
Nabi, H., Jensen, K. Y., Westermann, R., Hendricks, O., Jensen, D. V., Loft, A. G., Just, S. A., Pedersen, J. K., Danebod, K., Munk, H. L., Kristensen, S., Colic, A., Thygesen, P. H., Ammitzbøll, M., Chrysidis, S., Mehnert, F., Steen Krogh, N., Hetland, M. L. & Glintborg, B., 1 Jan 2025, In: Therapeutic Advances in Musculoskeletal Disease. 17Research output: Contribution to journal › Journal article › Research › peer-review
-
Adalimumab Biosimilar-to-biosimilar Switch in Patients with Inflammatory Rheumatic Diseases – Real-world Evidence from the Nationwide Danish Registry
Jensen, K. Y., Nabi, H., Jensen, D. V., Pedersen, J., Hendricks, O., Loft, A. G., Colic, A., Danebod, K., Kristensen, S., Munk, H., Lomborg, N., Manilo, N., Chrysidis, S., Just, S., Linauskas, A., Højgaard, P., Thygesen, P. H., Kildemand, M., Østgård, R. D. & Hetland, M. L. & 1 others, , 2024, p. Arthritis Rheumatol.; volume 76, suppl 9.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review
-
Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients
Nabi, H., Ibsen, R., Ibsen, M., Kjellberg, J., Hetland, M. L. & Glintborg, B., 1 Jan 2024, In: Therapeutic Advances in Musculoskeletal Disease. 16, p. 1759720X241289391Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
A MACHINE LEARNING MODEL FOR IDENTIFYING IMPORTANT CLINICAL VARIABLES AND PREDICTING ONE-YEAR TREATMENT RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS PERFORMING AN INFLIXIMAB BIOSIMILAR-TO-BIOSIMILAR SWITCH
Prenga, N., Nabi, H., Krogh, N. S., Akkoc, A., Hetland, M. L. & Glintborg, B., 2023, p. Annals of the rheumatic diseases, vol. 82 suppl. 1, page 494.Research output: Contribution to conference › Conference abstract for conference › Research › peer-review